Deftones' Chi Cheng's family consider stem cell therapy to aid recovery
By Dr. Matthew Watson
November 25, 2012 12:54
Former bassist is said to be still in a "partially conscious state" four years on from car accident.
Photo: Tom Oxley/NME
Former Deftones bassist Chi Cheng's family are considering stem cell therapy to aid his recovery from a car accident which put him in a coma in 2008.
Cheng is said to be in a "partially conscious state" and is unable to speak, although he can move his legs on command. The bassist has been in and out of hospitals over the past four years and only got home to recover in June this year.
Now, according to Revolver Magazine, the family is considering alternative therapy in order to speed up Cheng's recovery, as they say the last few months have been a struggle for him.
His brother, Ming Cheng, said: "Once his health gets a little better, we'll start looking into other options...but they don't even do it (stem cell therapy) in the US yet.
"It's a miracle he's still with us," he added. "He's alive and kicking and he's fighting, and I think there's a reason for it. I'm hoping there's a light at the end of the tunnel for Chi."
Deftones released their new album 'Koi No Yokan' on November 12. You can stream the new record, which features 'Entomb (Dazzle)', 'Swerve City', 'Graphic Nature', 'Goon Squad' and 'Leathers', below.
The band tour the UK in 2013. They will play five dates, kicking off at Glasgow's Barrowland on February 15, before heading to Nottingham, Manchester, Birmingham and finishing at London's 02 Brixton Academy (20).
View post:
Deftones' Chi Cheng's family consider stem cell therapy to aid recovery
Uncategorized
Comments Off on Deftones' Chi Cheng's family consider stem cell therapy to aid recovery |
November 25th, 2012
Nature Biotechnology Study Highlights New Myelin Specific Approach to Treat … – The Herald | HeraldOnline.com
By Dr. Matthew Watson
 Daily Mail | Nature Biotechnology Study Highlights New Myelin Specific Approach to Treat ... The Herald | HeraldOnline.com SARATOGA, Calif. — The Myelin Repair Foundation (MRF) today announced the results of a new peer-reviewed research study published in Nature Biotechnology highlighting a targeted, novel approach for multiple sclerosis (MS). By utilizing the Myelin ... Nanoparticles deliver antigen to trick the immune system in MSFierceDrugDelivery MS: Nanoparticle Discovery May Halt MS Without Total Immune System ...Guardian Express Nanoparticles Show Potential for Treating MSCBS 47 |
Uncategorized
Comments Off on Nature Biotechnology Study Highlights New Myelin Specific Approach to Treat … – The Herald | HeraldOnline.com |
November 25th, 2012
Biotechnology organization sees IP rights essential – China Daily
By Dr. Matthew Watson
China Daily | Biotechnology organization sees IP rights essential China Daily "A patent often brings far greater value than one could ever imagine," said Dr Terence L.T. Lau, chief operating officer and general manager of Hong Kong Biotechnology Organization (HKBIO), which innovates the patented biotech product - H5 series of ... |
Uncategorized
Comments Off on Biotechnology organization sees IP rights essential – China Daily |
November 25th, 2012
California Stem Cell Agency Still in Talks on $40 Million for StemCells, Inc.
By Dr. Matthew Watson
The California stem cell agency and
StemCells, Inc., are still trying to reach agreement on a deal in
which the company would receive $40 million from the state's
taxpayer-funded research effort.
in matching funds required from the Newark, Ca., firm under the terms
of the two awards approved in July and September. The latter award
was okayed on a 7-5 vote by the governing board after it was rejected
twice by the agency's reviewers.
Report queried the agency about the status of the awards. Kevin
McCormack, the agency's spokesman, replied,
“We are still in talks with them over
the terms of the funding. Hopefully, we'll have an agreement soon.”
applications after they are approved by the agency's governing board
to be sure that all conditions are being met. However, in the case of
the September award to StemCells, Inc., CIRM's governing board took
the unusual step of publicly stating that the firm must demonstrate
it has the $20 million in matching funds before it receives any
payments from CIRM. The board did not take that sort of public
position on the $20 million grant approved earlier in the summer,
although matching funds are required in that case as well.
stem cell agency, Robert Klein, appeared twice before the board to
lobby for approval of the second award to StemCells, Inc., which is a
publicly traded firm.. It was the first such appearance by Klein
before his former colleagues since leaving the agency in June 2011.
attracted attention from the Los Angeles Times last month. Pulitzer
Prize-winning columnist Michael Hiltzik wrote that the process was “redolent of cronyism.” He said a “charmed relationship”
existed among StemCells, Inc., its “powerful friends” and the
stem cell agency.
Source:Stem Cell Therapy
Comments Off on California Stem Cell Agency Still in Talks on $40 Million for StemCells, Inc. |
November 25th, 2012
Texas Flap Looms Over California Stem Cell Agency’s Grant Appeals
By Dr. Matthew Watson
In nine days, the California stem cell
agency plans to take another crack at finding ways to curb its
free-wheeling appeal process involving scientists whose applications
for millions have been rejected by reviewers.
to researchers who need the cash to keep their labs running and remain in good standing with their host institutions.
record-breaking number of researchers made public appeals featuring
emotional patient advocates. Even the former chairman of the agency,
Robert Klein, made a two-time pitch for one applicant. Board members
later complained publicly about “arm-twisting,” lobbying and“emotionally charged presentations.”
meeting in Oakland -- with teleconferencing sites in San Francisco,
Irvine, Palo Alto, Seattle and Rochester, N.Y. -- contains few clues
on what the panel is hoping to specifically accomplish in next week's
90-minute session.
the transcript from the Oct. 24 meeting, during which CIRM President
Alan Trounson described the problem as “very critical.” He said,
“I think this is a very serious
matter that could really bite us very hard in a similar way to what's
happened in Texas. Unless we come up with some kind of process that
really addresses the science, it's a very large concern.”
mass resignations of reviewers at that state's $3 billion cancer
research effort. Questions have been raised about integrity of its grant review process and the program's political and biotech industry
relationships. James Drew of the Dallas Morning News produced a bit of an overview this week. In another piece, Eric Berger of the
Houston Chronicle provided quotes from emails from the infighting on
a controversial $18 million grant.
be also discussed at the agency's board meeting Dec. 12 in Los Angeles.
The board hopes to wrap up its action by late January.
to the agency at info@cirm.ca.gov.
Source:Stem Cell Therapy
Comments Off on Texas Flap Looms Over California Stem Cell Agency’s Grant Appeals |
November 25th, 2012
Pomeroy Moving On, Will Leave Stem Cell Board
By Dr. Matthew Watson
Claire Pomeroy, one of the longtime
members of the governing board of the $3 billion California stem cell agency,
will be leaving her position at UC Davis and the stem cell board next
June.
dean of the medical school. In a telephone interview, she told the
California Stem Cell Report that she is examining a “few select
opportunities” to work at a national level on health reform and
health policy issues.
 |
| Claire Pomeroy UC Davis photo |
Washington, D.C., working on health issues on behalf of the
University of California during the transition period before she
leaves her position in California.
shortly before the Golden State's stem cell agency was created in
2004. At that time, UC Davis had what she called a “fledgling”
stem cell research effort. Today the school has chalked up $128 million in
grants from the stem cell agency, ranking fifth among institutions
funded by the agency.
agency “catalyzed development of our program,” which she said has
risen to “national prominence.”
agency board was also instrumental in attracting a $100 million grant
from the Moore Foundation to start a new school of nursing at UC
Davis in 2009. Through her service on the board, she met Ed Penhoet,
who also served on the board and was one of the co-founders of Chiron
and then president of the Moore Foundation. Subsequently, Penhoet
called her for lunch to discuss her thoughts on nursing education,
and developments moved on from there.
nation's largest grant for nursing education, according to the Moore Foundation.
Source:Stem Cell Therapy
Comments Off on Pomeroy Moving On, Will Leave Stem Cell Board |
November 25th, 2012
‘The Knoepfler Award:’ Recognizing Risk and Those Who Make a Difference
By Dr. Matthew Watson
A UC Davis stem cell researcher-blogger has announced a “stem cell person of the year” award
complete with a $1,000 cash prize that he is putting up himself.
stem cell scientist in the U.S. actively blogging on the subject,
said he has decided to put his money where his mouth is.
including one for a scientist. Three days after the item aappeared, UC Davis
featured Knoepfler in a press release that included a video of
Knoepfler explaining the effort.
 |
| Paul Knoepfler UC Davis photo |
He said he wanted to go beyond “old
fashioned awards” given by “stodgy committees.” Knoepfler said he
is seeking to recognize that stem cell research is “transcending the
lab.”
is “to advance the stem cell field and give credit to those who
make a real difference.”
“The criteria are that the person
made a truly outstanding difference in the stem cell field for 2012.
The winner could be a scientist, a patient advocate, someone in
industry, a student, a physician…really anyone who has made the
field better. For non-scientist nominees I’m particularly
interested in those who took personal risks or gave of themselves to
help others. For scientists I am looking for outstanding scientific
achievement and in particular out-of-the-box thinking. Folks in any
country are eligible.”
Self-nominations are permissible. Knoepfler plans to pick five
finalists and interview them by phone. He also plans an online vote
that he said “may” influence his decision.
Source:Stem Cell Therapy
Comments Off on ‘The Knoepfler Award:’ Recognizing Risk and Those Who Make a Difference |
November 25th, 2012
California Stem Cell Agency Blogs on Geron Clinical Trial
By Dr. Matthew Watson
The California stem cell agency
published an article online last week concerning the hESC clinical
trial that Geron abandoned last year, dealing mainly with one of the
participants in the program.
about whether the $3 billion research program is likely to fund the
trial once again, should BioTime, Inc., of Alameda, Ca., be
successful in acquiring the assets of once was the first hESC
clinical trial in the United States. The agency loaned Geron $25
million a few months before the company cancelled the trial.
manager, simply wrote,
“They (BioTime) would need to apply
for a loan if they want CIRM to financially support the continued
trial.”
BioTime could apply for has a deadline of Dec. 18 for letters of
intent. In addition to a loan, a grant is also a possibility.
enrolled in the clinical trial shortly before Geron said it was
dropping the effort for financial reasons. Adams interviewed Sharify
before an audience of scientists.
“Katie told me that it would be
impossible not to hope that a trial would help her, but that by the
time she made the decision to participate she knew she was doing it
to further science, not necessarily to further her own recovery. She
told the audience, 'I was part of something that was bigger than me,
and bigger than all of you.'”
UC Davis also wrote about the BioTime-Geron deal last week. Noting
that Geron's decision a year ago left many “upset to put it
mildly,” Knoepfler said the “idea of BioTime buying the Geron
stem cell program is a great one that provides new hope on many
levels.”
Source:Stem Cell Therapy
Comments Off on California Stem Cell Agency Blogs on Geron Clinical Trial |
November 25th, 2012
Researcher Alert: Keeping Tabs on the Stem Cell Exchequer
By Dr. Matthew Watson
The California stem cell agency has
posted the dates for meetings of its board of directors for 2013
with most of the sessions scheduled for the San Francisco Bay Area.
Diego in August, and another in Los Angeles 13 months from now. The
other five are in Northern California. Not yet on the schedule is a board workshop in early January that will be open to the public.
and others? The board controls the purse strings to $3 billion for research grants and determines what areas are to be funded. Astute scientists would do well to take in the sessions.
They offer insights into board thinking and opportunities to deal
with the agency staff and directors on an informal basis. Only a
handful of researchers – or less – attend the meetings on a
regular basis, but have been well-served by the time spent.
Source:Stem Cell Therapy
Comments Off on Researcher Alert: Keeping Tabs on the Stem Cell Exchequer |
November 25th, 2012
Introduction To Stem Cell Therapy For Parkinson’s And Alzheimer’s Diseases | Stem Cell Malaysia – Video
By Sykes24Tracey
Introduction To Stem Cell Therapy For Parkinson #39;s And Alzheimer #39;s Diseases | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy projects so much potential and hope for patients of different illnesses. This is due to the unique characteristics of stem cells. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:3 1ratingsTime:03:51More inPeople Blogs
Here is the original post:
Introduction To Stem Cell Therapy For Parkinson's And Alzheimer's Diseases | Stem Cell Malaysia - Video
Uncategorized
Comments Off on Introduction To Stem Cell Therapy For Parkinson’s And Alzheimer’s Diseases | Stem Cell Malaysia – Video |
November 23rd, 2012
24K Gold – Video
By JoanneRUSSELL25
24K Gold
Get the best offer here redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB0079QOQRG Product Description 24K Gold Experience the Anti-Aging Power of the New Generation 24K Nano Gold Stem Cell Therapy Mask. This excellent product by BeautyMedica Lab offers an innovative Transdermal Delivery System with a unique blend of transforming growth factors (TGF), amino acids, antioxidants and peptides.Sheet form of the mask makes it extremely easy to apply to the face and allowing the ingredients to be absorbed into the skin slowly melting under body temperature. The Mask was formulated to Re-activate stem cells and stimulate new skin development. Increase collagen production and elastin synthesis. Minimize appearance of fine lines and wrinkles. Enhance moisture with Y-PGA and refine skin structure. Whiten the skin and reduce melanin. Restore youthful healthy looking skin and creates radiant skin appearance.For more info, please visit 24K Gold Mask presentation video by Beauty Medical Laboratorys - http://www.youtube.comFrom:Bernarda YooViews:3 0ratingsTime:00:58More inScience Technology
View post:
24K Gold - Video
Uncategorized
Comments Off on 24K Gold – Video |
November 23rd, 2012
Biologic Cell – Video
By raymumme
Biologic Cell
Get the best offer here redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB0083UMZOI Product Description Biologic Cell Re-Activate your stem cells to make wrinkles disappear! Set of 4 - 1 oz. jars.Stem Cell Therapy is the newest bio-active topical cream that actually stimulates your own skin stem cells to grow smooth, supple, firm new skin.Three powerful ingredients, Phyko-AI-PF (increases skin production by 57%), Mitostime (re-activates stem cells), and Seractin (a youth compound targeted at decreasing your deepest wrinkles) all work together to help you turn back the clock.Results start to appear within 2 weeks of regular use.From:Lilliam FogleViews:2 0ratingsTime:00:58More inNews Politics
Read the original post:
Biologic Cell - Video
Uncategorized
Comments Off on Biologic Cell – Video |
November 23rd, 2012
Fifty50 24K Gold – Video
By JoanneRUSSELL25
Fifty50 24K Gold
Buy from Amazon US redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fexec%2Fobidos%2FASIN%2FB007927WAS%2Fhealth%5Fhope%2D20 Product Description Fifty50 24K Gold Experience the Anti-Aging Power of the New Generation 24K Nano Gold Stem Cell Therapy Mask. This excellent product by BeautyMedica Lab offers an innovative Transdermal Delivery System with a unique blend of transforming growth factors (TGF), amino acids, antioxidants and peptides.Sheet form of the mask makes it extremely easy to apply to the face and allowing the ingredients to be absorbed into the skin slowly melting under body temperature. The Mask was formulated to Re-activate stem cells and stimulate new skin development. Increase collagen production and elastin synthesis. Minimize appearance of fine lines and wrinkles. Enhance moisture with Y-PGA and refine skin structure. Whiten the skin and reduce melanin. Restore youthful healthy looking skin and creates radiant skin appearance.For more info, please visit 24K Gold Mask presentation video by Beauty Medical Laboratorys - http://www.youtube.com Disclaimer: Hope is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon. Amazon and the Amazon logo are trademarks of Amazon, Inc. or its affiliates.From:Mi WadsworthViews:0 0ratingsTime:00:58More inPeople Blogs
See the article here:
Fifty50 24K Gold - Video
Uncategorized
Comments Off on Fifty50 24K Gold – Video |
November 23rd, 2012
Stem Cell Therapy For Alzheimer’s Disease | Stem Cell Malaysia – Video
By raymumme
Stem Cell Therapy For Alzheimer #39;s Disease | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy for Alzheimer #39;s Disease is currently in research and soon there may be a cure using stem cells treatment. Stem cell therapy through non-medical channel using a legal and licensed oral placenta product has produced amazing effects on an 81 years old, stage 7 Alzheimer #39;s sufferer. The effects were shockingly effective beyond words. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:0 0ratingsTime:21:27More inScience Technology
More here:
Stem Cell Therapy For Alzheimer's Disease | Stem Cell Malaysia - Video
Uncategorized
Comments Off on Stem Cell Therapy For Alzheimer’s Disease | Stem Cell Malaysia – Video |
November 23rd, 2012
Stem Cell Therapy Overview | Stem Cells Treatment | Stem Cell Malaysia – Video
By JoanneRUSSELL25
Stem Cell Therapy Overview | Stem Cells Treatment | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy is getting a lot of attention in the news and media these days. This video gives an overview of what stem cell therapy is all about. The content will help people without the scientific background to understand the important elements of stem cell therapy. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:0 1ratingsTime:20:17More inScience Technology
Read more here:
Stem Cell Therapy Overview | Stem Cells Treatment | Stem Cell Malaysia - Video
Uncategorized
Comments Off on Stem Cell Therapy Overview | Stem Cells Treatment | Stem Cell Malaysia – Video |
November 23rd, 2012
Official Presentation of Live Cell Therapy Using Purtier Placenta | Stem Cell Malaysia – Video
By NEVAGiles23
Official Presentation of Live Cell Therapy Using Purtier Placenta | Stem Cell Malaysia
stemcellmalaysia.com Live cell therapy is a very effective stem cell therapy for improving health and even disease treatment other than for beauty and anti-aging. Purtier Placenta is a live cell therapy using deer placenta stem cells from New Zealand. Watch this official presentation for a complete understanding of live cell therapy with Purtier Placenta. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:0 0ratingsTime:08:59More inScience Technology
Read the rest here:
Official Presentation of Live Cell Therapy Using Purtier Placenta | Stem Cell Malaysia - Video
Uncategorized
Comments Off on Official Presentation of Live Cell Therapy Using Purtier Placenta | Stem Cell Malaysia – Video |
November 23rd, 2012
DWAH Stem Cell Therapy. – Video
By Sykes24Tracey
DWAH Stem Cell Therapy.
From:Dundas West AHViews:1 0ratingsTime:03:53More inPets Animals
Read the original here:
DWAH Stem Cell Therapy. - Video
Uncategorized
Comments Off on DWAH Stem Cell Therapy. – Video |
November 23rd, 2012
Bone Tissue Engineering Study Led by Ghent University Improves Treatment of Bone Deficits Using Cryo-Save Stem Cells
By raymumme
ZUTPHEN, the Netherlands, November 20, 2012 /PRNewswire/ --
Ghent University and Cryo-Saves collaboration overcomes the restrictions encountered in bone tissue engineering of large size bone grafts. This traditional tissue engineering (TE) is often limited to the outside region resulting in a localized, non-uniform tissue formation. For the present study, Cryo-Save provided cryopreserved stem cells that show promising results to obtain a uniform cell distribution and a high cell density in the centre of bone grafts. This will improve bone deficit treatments for large size bone grafts.
Cryo-Save, Europes leading family stem cell bank, participated in a high-level tissue engineering study, headed by Dr. Heidi A. Declercq, PhD and her team from Ghent University (group leader, Prof. Dr. M. Cornelissen), Belgium, on new practices to build artificial bone tissue with stem cells. Close collaboration between Cryo-Save and Ghent University led the company to manufacture and provide cryopreserved stem cells derived from adipose tissue (ADSC) for the study. The article "Bone grafts engineered from human adipose-derived stem cells in dynamic 3D-environments" was recently published in Biomaterials, one of the most widely read and influential scientific journal in the field of Tissue Engineering and Biomaterials.
Thanks to the work of Dr. Declercq, modular tissue engineering offers an innovative way to create large bone grafts obtained with ADSC-seeded on microcarriers in a bottom-up approach. The strategy aims to engineer small volume, high-quality microtissues and the subsequent assembly in-vitro or in-vivo into larger tissue constructs upon implantation. In this study, ADSC-seeded microcarriers were exploited to prepare modular tissues (microtissues) as building blocks followed by self-assembling into macrotissues in-vitro. As a result, Dr. Declercq demonstrated that ADSC are as good as bone marrow in bone tissue engineering application revealing similar morphology, calcification level and osteogenic genes expression but the use of ADSC can substitute the painful collection of bone marrow stem cells.
The outcomes of the study are very promising for treatment of bone deficits. Dr. Declercq sees great hopes in bone tissue engineering and says: "Modular tissue engineering is a promising approach to create large bone grafts as it encounters most of the limits in traditional tissue engineering. Moreover, the combination of adipose-derived stem cells in this bottom-up approach is excellent because adipose-derived stem cells are a great source for tissue engineering purposes. A high amount of cells with high proliferation and differentiation capacity can be obtained from abundant adipose tissue sources".
Cryo-Save is thrilled to have played a major role by providing cryopreserved ADSC for use in this study. It is an integral part of Cryo-Saves activities to support research and to collaborate with leading universities, physicians and stem cell scientists, with the aim to improve clinical applications.
Cryo-Save, the leading international family stem cell bank, stores more than 225,000 samples from umbilical cord blood, cord tissue and adipose tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in 40 countries on three continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.
Cryo-Save: http://www.cryo-save.com/group
Cryo-Save Group N.V.
Bone Marrow Stem Cells
Comments Off on Bone Tissue Engineering Study Led by Ghent University Improves Treatment of Bone Deficits Using Cryo-Save Stem Cells |
November 21st, 2012
cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy – Video
By JoanneRUSSELL25
cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy
http://www.cordbloodrecommendation.com These diseases include blood related, genetic and neurotic disorders. ""Banking the umbilical cord blood when your baby is born is a relatively new idea, the first operation using it to help cure a child with Leukemia was only done a little over 10 years ago. After processing of cells, comes the next procedure of cord blood preservation. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. With people not fully understanding how important stem cells could be for us, everybody agrees that more research need to be done in order to help understand all that. If there is any complication during delivery, the entire idea is abandoned. It is always wise to preserve this waste blood of the baby which is otherwise thrown away. You are injecting the patient with those same cells that created him!This can be done with the bone marrow transplants tooYes, stem cells are found in bone marrows too. It is a simple and ...From:luisantafeViews:0 0ratingsTime:01:31More inScience Technology
Continued here:
cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy - Video
Uncategorized
Comments Off on cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy – Video |
November 21st, 2012
Stem cells achieve sustained heart function improvement in heart attack patients – Video
By raymumme
Stem cells achieve sustained heart function improvement in heart attack patients
From Louisville - Stem cell therapy has been shown to sustain heart function improvement in heart attack patients in a phase 1 clinical presented at the AHA #39;s Scientific Sessions. The trial, known as SCIPIO for Stem Cell Infusion in Patients with Ischemic CardiOmyopathy, randomized 33 patients diagnosed with heart failure after suffering a heart attack to either cardiac stem cells or no stem cells. Researchers found that patients who received the stem cells had great improvement in their heart function, and that this improvement was sustained 2 years following infusion. Patients who did not receive stem cells had no improvement. There were no adverse effects of the treatment. One patient #39;s heart experienced such dramatic improvement that there was no sign of heart failure at all. Said Dr. Roberto Bolli, lead author of the study, "Anyone who looks at his heart now would not imagine that this patient was (ever) in heart failure or that he had a heart attack."From:insidermedicineViews:0 0ratingsTime:00:59More inScience Technology
The rest is here:
Stem cells achieve sustained heart function improvement in heart attack patients - Video
Uncategorized
Comments Off on Stem cells achieve sustained heart function improvement in heart attack patients – Video |
November 21st, 2012